SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-15-016709
Filing Date
2015-03-17
Accepted
2015-03-17 15:48:15
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHANDELPHI BIOINVESTMENTS VIII, L.P.DELPHI MANAGEMENT PARTNERS VIII, L.L.C.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v404669_13da.htm SC 13D/A 93741
  Complete submission text file 0001144204-15-016709.txt   95529
Mailing Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025 650-854-9657
DELPHI VENTURES VIII LP (Filed by) CIK: 0001436285 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 11045 ROSELLE STREET SUITE 200 San Diego CA 92121
Business Address 11045 ROSELLE STREET SUITE 200 San Diego CA 92121 858-366-6900
TANDEM DIABETES CARE INC (Subject) CIK: 0001438133 (see all company filings)

IRS No.: 204327508 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87718 | Film No.: 15706263
SIC: 3841 Surgical & Medical Instruments & Apparatus